This event was published on 29 October
Registration Open
Webinar: AMRの脅威と製薬企業の責任 The Threat of AMR and Pharmaceutical Responsibility

Webinar: AMRの脅威と製薬企業の責任 The Threat of AMR and Pharmaceutical Responsibility

Webinar | 22 Dec 2025 15:00–16:00 Tokyo

この講演の言語は日本語です
This presentation will be delivered in Japanese

テーマ
AMRの脅威と製薬企業の責任:製薬業界をあげた活動とSHIONOGIグループの取り組み

PSCIアカウントに登録/ログイン後、申し込みができます。申し込みは12月17日午後5時までとなります。参加ガイドメールは12月18日に送信されます。

講演者
大橋 興三,コーポレートガバナンス部 総務EHS担当者

SHIONOGIグループにおけるEHS(環境・健康・安全)統括組織での3年間の経験を有し、AMR(薬剤耐性)対策における責任ある製造の推進を担当。AMR Industry AllianceのManufacturing Working Groupメンバーとして、国際的な枠組みにおける製造環境改善にも取り組んでいる。以前は18年間にわたり臨床開発部門にて新薬の開発業務に従事し、抗菌薬の開発にも携わる。

概略
薬剤耐性菌(AMR:Antimicrobial Resistance)は、世界の医療に深刻な影響を及ぼす重要な課題です。本Webinarでは、AMRの基本的な知識をわかりやすく解説し、製薬業界がどのように対応すべきかをご紹介します。
具体的には、AMR Industry Allianceによる抗菌薬製造基準(Antibiotic Manufacturing Standard)や、新たな認証制度を取り上げ、業界全体で進められている取り組みを理解します。
さらに、SHIONOGIグループが推進する具体的な施策についてもご紹介し、持続可能な医療の実現に向けた道筋を考えます。
AMR問題の本質と解決へのアプローチを学ぶ貴重な機会です。ぜひご参加ください。

Topic
The Threat of AMR and Pharmaceutical Responsibility: Industry-Wide Initiatives in the Pharmaceutical Sector and SHIONOGI Group’s Commitment

Presenter
Kozo Ohashi, EHS Management Group Member, Corporate Governance Department, Shionogi

Kozo Ohashi has three years of experience in the Environmental, Health, and Safety (EHS) management division of the SHIONOGI Group, where he led initiatives for responsible manufacturing in the context of antimicrobial resistance (AMR). He is also a member of the Manufacturing Working Group of the AMR Industry Alliance, contributing to global efforts to improve manufacturing practices in the fight against AMR. Prior to this role, he spent 18 years in clinical development, contributing to the research and development of new drugs, including antibiotics.

Introduction
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar will provide a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It will introduce the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern. We look forward to your participation.

Type
Webinar
Date
22 Dec 2025 15:00–16:00 Tokyo
Language
Japanese
Add To Calendar

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent Inc
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 17 Dec 2025
If you have a user account, please log in before registering.